A16G (p.Ala16Gly) variant of EGFR (Epidermal growth factor receptor)
A16G (p.Ala16Gly) in EGFR (Epidermal growth factor receptor) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.25 / 1. The record also includes population frequency data and structural context.
A16G (p.Ala16Gly) variant details
- p.Ala16Gly
- Ensembl rs2128853431
- Missense
- Variant Prioritization Score for Impact Estimate 0.246
- REVEL 0.19
- MetaLR 0.25
- MetaSVM -0.88
- CADD 12.40
- PolyPhen-2 0.00
- SIFT 0.38
- Population evidence available
- Structural context available